| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3284421 | Clinical Gastroenterology and Hepatology | 2009 | 8 Pages |
Abstract
The use of anti-TNF agents with immunomodulators is associated with an increased risk of NHL in adult CD patients, but the absolute rate of these events remains low and should be weighed against the substantial benefits associated with treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Corey A. Siegel, Sadie M. Marden, Sarah M. Persing, Robin J. Larson, Bruce E. Sands,